Abstract
Purpose
This study is to investigate whether poly(ethylene glycol) (PEG)-b-poly(L-histidine) [PEG-polyHis] can reduce aggregation of insulin in aqueous solutions on agitation by forming ionic complexes.
Materials and Methods
Insulin aggregation on agitation was monitored spectrophotometrically and by fibrillation studies with a dye Thioflavin T. Pluronic F-127 as a control and PEG-polyHis as a novel multifunctional excipient were added to prevent destabilization of insulin. Conformation of insulin was evaluated in a circular dichroism (CD) study.
Results
Ionic interactions between insulin and PEG-polyHis were induced in the pH range: 5.5–6.5. pH 5.5 was selected for further evaluation based on particle size/zeta potential studies. Ionic complexation with PEG-polyHis is more effective at pH 5.5 in stabilizing insulin (75% of insulin retained versus 0% with no excipient) than Pluronic F-127 (42% retained). PEG-polyHis guards against insulin aggregation in non-complexing pH conditions (pH 7.4), 64% insulin retained versus 58% with F-127 and 0% with no excipient) pointing to the potential role played by PEG in modulation of insulin surface adsorption. Rate of fibrillation was higher for plain insulin compared with addition of PEG-polyHis and Pluronic F-127 at both pH.
Conclusions
Understanding and manipulation of such polyelectrolyte-protein complexation will likely play a role in protein stabilization.
Similar content being viewed by others
References
J. L. Selam. External and implantable insulin pumps: current place in the treatment of diabetes. Exp. Clin. Endocrinol. Diabetes 109(Supp2):S333–S340 (2001).
H. M. Walter, R. Timmler, and H. Mehnert. Stabilized human insulin prevents catheter occlusion during continuous subcutaneous insulin infusion. Diabetes Res. 13(2):75–77 (1990).
S. Sato, C. D. Ebert, and S. W. Kim. Prevention of insulin self-association and surface adsorption. J. Pharm. Sci. 72(3):228–232 (1983).
A. K. Banga and R. Mitra. Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. J. Drug Target. 1(4):341–345 (1993).
G. C. Visor, K. P. Tsa, J. Duffy, M. D. Miller, T. Calderwood, and V. M. Knepp. Quantitative evaluation of the stability and delivery of interleukin-1B by infusion. J. Parenter. Sci. Technol. 44:130–137 (1990).
L. T. Vlasveld, J. H. Beijnen, J. J. Sein, E. M. Rankin, C. J. M. Melief, and A. Hekman. Reconstitution of recombinant interleukin-2 (rIL-2): a comparative study of various rIL-2 muteins. Eur. J. Cancer 29A:1979–1981 (1993).
S. T. Tzannis, W. J. M. Hrushesky, P. A. Wood, and T. M. Przybycien. Adsorption of a formulated protein on a drug delivery surface. J. Colloid Interface Sci. 189:216–228 (1997).
Y. J. Wang and M. Hanson. Parenteral formulations of peptides and proteins: Stability and stabilizers. J. Parenter. Sci. Technol. 42:1–26 (1988).
W. Wang. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185:129–188 (1999).
V. Sluzky, A. M. Klibanov, and R. Langer. Mechanism of insulin aggregation and stabilization in agitated aqueous solutions. Biotechnol. Bioeng. 40:895–903 (1992).
W. D. Lougheed, A. M. Albisser, H. M. Martindale, J. C. Chow, and J. R. Clement. Physical stability of insulin formulations. Diabetes 32:424–432 (1983).
A. S. Chawla, I. Hinberg, P. Blais, and D. Johnson. Aggregation of insulin, containing surfactants, in contact with different materials. Diabetes 34:420–424 (1985).
H. Thurow and K. Geisen. Stabilization of dissolved proteins against denaturation at hydrophobic interfaces. Diabetologia 27:212–218 (1984).
U. Grau. Chemical stability of insulin in a delivery system environment. Diabetologia 28:458–463 (1985).
E. S. Lee, H. J. Shin, K. Na, and Y. H. Bae. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control. Release 90(3):363–374 (2003).
D. W. Pack, D. Putnam and R. Langer. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol. Bioeng. 67(2):217–223 (2000).
J. H. Kim, A. Taluja, K. Knutson, and Y. H. Bae. Stability of Bovine Serum Albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. J. Control. Release 109:86–100 (2005).
P. L. Wang and T. P. Johnston. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407. J. Parenter. Sci. Technol. 47:183–189 (1993).
M. Katakam and A. K. Banga. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm. Dev. Technol. 2(2):143–149 (1997).
E. S. Lee, K. Na and Y. H. Bae. Polymeric micelles for tumor pH and folate-mediated targeting. J. Control. Release 91(1–2):103–113 (2003).
A. Ahmad, I. S. Millett, S. Doniach, V. N. Uversky and A. L. Fink. Stimulation of Insulin fibrillation by urea-induced intermediates. J. Biol. Chem. 279(15):14999–15013 (2004).
J. M. Davis, T. Arakawa, T. W. Strickland and D. A. Yphantis. Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 26(9):2633–2638 (1987).
T. Toyoda, T. Itai, T. Arakawa, K. H. Aoki, and H. Yamaguchi. Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J. Biochem. (Tokyo) 128(5):731–737 (2000).
J. L. England. Stabilization and release effects of Pluronic F127 in protein drug delivery. J. Undergrad. Sci. (Harvard University) 5(2):17–24 (2001).
A. Ahmad, I. S. Millett, S. Doniach, V. N. Uversky, and A. L. Fink. Partially folded intermediates in insulin fibrillation. Biochemistry 42:11404–11416 (2003).
A. Ahmad, V. N. Uversky, D. Hong, and A. L. Fink. Early events in the fibrillation of monomeric insulin. J. Biol. Chem. 280(52):42669–42675 (2005).
V. Sluzky, J. A. Tamada, A. M. Klibanov, and R. Langer. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. U. S. A. 88:9371–9381 (1991).
M. Katakam, L. N. Bell, and A. K. Banga. Effect of surfactants on physical stability of recombinant human growth hormone. J. Pharm. Sci. 84(6):713–716 (1995).
O. L. Johnson, W. Jaworowicz, J. L. Cleland, L. Bailey, M. Charnis, E. Duenas, C. Wu, D. Shepard, S. Magil, T. Last, A. J. S. Jones, and S. D. Putney. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14:730–735 (1997).
R. C. Lee, L. P. River, F. S. Pan, and R. L. Wollmann. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc. Natl. Acad. Sci. U. S. A. 89:4524–4528 (1992).
J. D. Marks, C. Y. Pan, T. Bushell, W. Cromie, and R. C. Lee. Amphiphilic tri-block provide potent membrane-targeted neuroprotection. FASEB J. 15:1107–1109 (2001).
M. A. Andersson and R. Hatti-Kaul. Protein stabilizing effect of polyethyleneimine. J. Biotechnol. 72:21–31 (1999).
A. S. Ganhorn, D. W. Green, A. D. Hershey, R. M. Gould, and B. V. Plapp. Kinetic characterization of yeast alcohol dehydrogenases. J. Biol. Chem. 262:3754–3761 (1987).
M. Teramoto, H. Nishibue, H. Ogawa, H. Kozono, K. Morita, and H. Matsuyama. Effect of addition of water-soluble cationic polymers on thermal stability and activity of glucose dehydrogenase. Colloids Surf., B Biointerfaces 7:165–171 (1996).
M. Teramoto, H. Nishibue, H. Ogawa, H. Kozono, K. Morita, H. Matsuyama, and K. Kajiwara. Effect of addition of polyethyleneimine on thermal stability and activity of glucose dehydrogenase. Appl. Microbiol. Biotechnol. 38:203–208 (1992).
K. Kaibara, T. Okazaki, H. B Bohidar, and P. L. Dubin. pH-induced coacervation in complexes of bovine serum albumin and cationic polyelectrolytes. Biomacromolecules 1(1):100–107 (2000).
J. Xia, P. L. Dubin, E. Kokufuta, H. Havel, and B. B. Muhoberac. Light scattering, CD, and ligand binding studies of ferrihemoglobin-polyelectrolyte complexes. Biopolymers 50(2):153–161 (1999).
J. M. Harris. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In J. M. Harris (ed.), Poly(ethylene glycol) Chemistry: Biochemical and Biomedical Applications, Vol. 1, Plenum Press, New York, 1992.
K. Hinds, J. J. Koh, L. Joss, F. Liu, M. Baudyš, and S. W. Kim. Synthesis and characterization of poly(ethylene glycol)-insulin conjugates. Bioconjug. Chem. 11:195–201 (2000).
E. Ron, T. Turek, E. Mathiowitz, M. Chasin, M. Hageman, and R. Langer. Controlled release of polypeptides from polyanydrides. Proc. Natl. Acad. Sci. U. S. A. 90:4176–4180 (1993).
E. V. Kudryashova, T. M. Artemova, A. A. Vinogradov, A. K. Gladilin, V. V. Mozhaev, and A. V. Levashov. Stabilization and activation of alpha-chymotrypsin in water-organic solvent systems by complex formation with oligoamines. Protein Eng. 16(4):303–309 (2003).
J. Gao and Y. P. L. Dubin. Binding of proteins to copolymers of varying hydrophobicity. Biopolymers 49(2):185–193 (1999).
L. E. Bromberg. Interactions among proteins and hydrophobically modified polyelectrolytes. J. Pharm. Pharmacol. 53:541–547 (2001).
Acknowledgements
This research was supported in part by an NIH grant GM72612. We thank Dr. Yu-Seok Youn for help in chromatographic procedures for insulin. Deepa Mishra, a fellow laboratory member helped in successful instruction of the RIA procedures and analyses and for valuable discussion and editing of the manuscript. Appreciation is also due to Dr. Michael Kay, Assistant Professor, Department of Biochemistry; University of Utah for his help in conducting and analyzing circular dichroism experiments. The authors would like to thank Dr. James N. Herron, Associate Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah for his advice on fluorescence analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taluja, A., Bae, Y.H. Role of a Novel Excipient Poly(Ethylene Glycol)-b-Poly(L-Histidine) in Retention of Physical Stability of Insulin in Aqueous Solutions. Pharm Res 24, 1517–1526 (2007). https://doi.org/10.1007/s11095-007-9270-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-007-9270-z